Sana Biotechnology (SANA) Current Leases (2020 - 2026)
Sana Biotechnology (SANA) posted Current Leases of $14.9 million for Q1 2026, little changed sequentially from $14.9 million in Q4 2025, and up 14.42% YoY from $13.0 million in Q1 2025.
Sana Biotechnology (SANA) Current Leases (2020 - 2026) Analysis & Trends
Sana Biotechnology has reported Current Leases for 7 years, with the latest figure at $14.9 million in Q1 2026.
- Quarterly Current Leases rose 14.42% year-over-year to $14.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.9 million (up 14.42% YoY) and the FY2025 annual result came in at $14.9 million, up 19.18% from the prior year.
- Current Leases steadied at $14.9 million in Q1 2026 per SANA's latest filing, from $14.9 million in the prior quarter.
- Over five years, Current Leases peaked at $14.9 million in Q4 2025 and troughed at $9.6 million in Q1 2022.
- A 5-year average of $12.6 million and a median of $12.9 million in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2024: Current Leases soared 146.42% in 2022, then dropped 22.44% in 2024.
- Over 5 years, Current Leases stood at $12.4 million in 2022, then gained by 6.47% to $13.2 million in 2023, then decreased by 5.01% to $12.5 million in 2024, then rose by 19.18% to $14.9 million in 2025, then declined by 0.4% to $14.9 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $14.9 million, $14.9 million, and $14.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Sana Biotechnology | 1.06 Bn | 1.06 Bn | - | 14.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.51 Mn |
| Mar 31, 2026 | 14.88 Mn |
| Dec 31, 2025 | 14.94 Mn |
| Sep 30, 2025 | 14.37 Mn |
| Jun 30, 2025 | 13.83 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Dec 31, 2024 | 12.53 Mn |
| Sep 30, 2024 | 10.60 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Mar 31, 2024 | 13.17 Mn |
| Dec 31, 2023 | 13.20 Mn |
| Sep 30, 2023 | 13.49 Mn |
| Jun 30, 2023 | 12.89 Mn |
| Mar 31, 2023 | 12.89 Mn |
| Dec 31, 2022 | 12.39 Mn |
| Sep 30, 2022 | 11.92 Mn |
| Jun 30, 2022 | 10.67 Mn |
| Mar 31, 2022 | 9.64 Mn |
| Dec 31, 2021 | 9.16 Mn |
| Sep 30, 2021 | 6.50 Mn |